IRulya Therapeutics QNCX
NASDAQ QNCX
$32.83 -1.85 (-5.33%)
At close: Oct 22, 2026 · 4:00 PM EDT

Quince Therapeutics (QNCX) Return on Equity [ROE] (2019 - 2025)

Updated

IRulya Therapeutics (QNCX) posted Return on Equity [ROE] of -890.64% for Q3 2025, down 774.73 percentage points from -115.92% a year earlier and down 567.20 percentage points from the prior quarter.

Analysis

Quince Therapeutics (QNCX) Return on Equity [ROE] (2019 - 2025) Analysis & Trends

For FY2024, IRulya Therapeutics' Return on Equity [ROE] came in at -98.63%, down 64.83 percentage points from FY2023.

  • Annual Return on Equity [ROE] shows a five-year change of -9.37 percentage points (FY2019 to FY2024).
  • In prior years, IRulya Therapeutics' Return on Equity [ROE] was -33.81% in FY2023 (+13.33 pp), -47.14% in FY2022 and -53.42% in FY2020 (+35.85 pp).
  • The Q3 2025 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q2 2019.
  • On a year-over-year basis, Return on Equity [ROE] has declined in each of the last six quarters, with an average year-over-year change of -181.56 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2022, with a gain of 82.31 percentage points; the weakest was Q3 2025, with a drop of 774.73 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -323.44% (Q2 2025), -249.18% (Q1 2025) and -151.38% (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 19.33%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.21%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 31.52%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 21.39%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 83.75%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -18.38%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.97%
10 IRulya Therapeutics 201.34 Mn 229.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -890.64%
Jun 30, 2025 -323.44%
Mar 31, 2025 -249.18%
Dec 31, 2024 -151.38%
Sep 30, 2024 -115.92%
Jun 30, 2024 -87.70%
Mar 31, 2024 -38.03%
Dec 31, 2023 -37.31%
Sep 30, 2023 -32.97%
Jun 30, 2023 -34.55%
Mar 31, 2023 -44.31%
Dec 31, 2022 -50.37%
Sep 30, 2022 18.90%
Jun 30, 2022 6.09%
Mar 31, 2022 1.28%
Sep 30, 2021 -63.41%
Jun 30, 2021 -58.21%
Mar 31, 2021 -50.35%
Dec 31, 2020 -42.66%
Sep 30, 2020 -34.91%
API Access

Quince Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=QNCX&period=max&api_key=YOUR_API_KEY